Effectiveness of an Integrated Care Program on Asthma Control and Inhaled Corticosteroids Adherence

Not Applicable

Completed

• Conditions: Asthma
• Interventions: Other: Integrated care program

• Registration Number: NCT02093013
• Lead Sponsor: Laval University

Brief Summary

The investigators propose to implement and evaluate an integrated care program for enhancing the care of patients with asthma in a region of Quebec province, Canada. The investigators will implement our intervention in a family medicine group practice setting and plan to deliver it to 150 experimental group subjects. The investigators will simultaneously study 300 control subjects who are receiving usual care in other regions of the province of Quebec. Our hypothesis is that the program will improve the quality of life of patients with asthma exposed to the program, asthma control, inhaled corticosteroid adherence, knowledge of asthma, and a number of variables that relate to the conceptual model selected as a framework for this study (the PRECEDE-PROCEED model of Green and Kreuter).

Detailed Description

Not available

Study Timeline

• Study Start: 2004-05
• Primary Completion: 2007-01
• Study Completion: 2007-07
• Study First Submitted: 2014-03-18
• Study First Submitted QC: 2014-03-19
• Study First Posted: 2014-03-20
• Status Verified: 2017-03
• Last Update Submitted: 2017-03-28
• Last Update Posted: 2017-03-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 349

Inclusion Criteria

Individuals aged 12 to 45 years, for whom the pharmacists had dispensed at least one anti-asthma drug in the previous six months were screened and randomly contacted by phone. Those who reported an asthma diagnosis and who were using a short-acting beta-2-agonist (SABA) >3 times a week (except before exercise) or a corticosteroid (inhaled or oral), irrespective of frequency were included.

Exclusion Criteria

Pregnancy, no prior asthma diagnosis, participation in an ongoing respiratory study, or another respiratory illness.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Integrated care program	Integrated care program	-

Primary Outcome Measures

Name	Time	Method
Asthma control	One year	The primary outcome was asthma control, measured with the validated Asthma Control Questionnaire.

Secondary Outcome Measures

Name	Time	Method
Adherence to ICS	One year	Adherence to medication for each participant reporting an inhaled corticosteroids (ICS) prescription was assessed using two measures; the validated Morisky medication adherence scale (MMAS-4) composed of 4 questions (yes/no) about past medication use patterns, and the medication possession ratio (MPR), a validated objective measure based on pharmacy records.

Trial Locations

Locations (1)

Centre hospitalier affilié universitaire de Québec; 🇨🇦 Québec, Quebec, Canada